Substituted acrylamide derivative and pharmaceutical composition comprising the same

Details for Australian Patent Application No. 2006244905 (hide)

Owner Daiichi Sankyo Company, Limited

Inventors Kimura, Tomio; Suda, Koji; Aoki, Kazumasa; Kaneko, Toshio

Agent Davies Collison Cave

Pub. Number AU-B-2006244905

PCT Pub. Number WO2006/121095

Priority 2005-140019 12.05.05 JP

Filing date 11 May 2006

Wipo publication date 16 November 2006

Acceptance publication date 10 September 2009

International Classifications

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

A61K 31/222 (2006.01)

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/36 (2006.01)

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/402 (2006.01) - 1-aryl-substituted, e.g. piretanide

A61K 31/4035 (2006.01)

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4402 (2006.01) - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 31/47 (2006.01) - Quinolines

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61P 1/02 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/14 (2006.01) Drugs for disorders of the metabolism

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/04 (2006.01) Antineoplastic agents

C07C 237/22 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

C07C 323/63 (2006.01) Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2006/121095 Priority application(s): WO2006/121095

10 September 2009 Application Accepted

  Published as AU-B-2006244905

14 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006244914-Crystal of indole derivative having piperidine ring and process for production thereof

2006244899-Intermolecular compound of fatty acid triglyceride